Global markets have been buoyed by robust stimulus measures from China, driving U.S. stocks to record highs and sparking optimism in the technology sector. As investors navigate these dynamic ...

We recently compiled a list of the 15 Worst 52-Week Low Stocks to Buy Now According to Short Sellers. In this article, we are ...

Catalyst’s primary revenue driver, Firdapse, faces potential generic competition after exclusivity ends in 2025. Read why I'm ...

Acumen Health Holdings, LLC, a professionally recommended, consumer-preferred dietary supplements company focused on eye health and companion animals, announced today that its subsidiary, PRN ...

Imexpharm Pharmaceutical Joint Stock Company is charting a significant growth trajectory by intensifying its research and development (R&D) initiatives as a strategic move to develop high-tech ...

Global markets have been buoyed by the Federal Reserve's recent decision to cut rates, with U.S. stocks reaching new highs ...

The rise of digitalisation and technological advancements has significantly transformed the logistics landscape, particularly ...

Prior to the COVID-19 pandemic, the activities of medical and pharmaceutical laboratories seldom received national or ...

Emcure Pharma stock price is up more than 19% from its listing price and over 56% from its IPO price. The pharma stock has ...

A new report led by Emily Carter and Elizabeth Zeitler *14 offers research and policy ideas, including carbon fiber ...

Future of Healthcategory US FDA approves GE HealthCare's diagnostic drug for heart disease September 27, 2024 Healthcare & Pharmaceuticalscategory US farmers call for vaccine option to fight bird ...